Pharmacological prevention of suicide in bipolar patients - A realizable target

Journal of Affective Disorders

Volumn 103, Issue 1-3, 2007, Pages 1-3

  Rihmer, Zoltán ^a,b  

^a NATIONAL INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Hungary)

^b SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; CARBAMAZEPINE; LITHIUM; MOOD STABILIZER; NEUROLEPTIC AGENT; VALPROATE SEMISODIUM;

BIPOLAR DISORDER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; EDITORIAL; FOLLOW UP; HEALTH CARE SYSTEM; HUMAN; LONG TERM CARE; MOOD DISORDER; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; SCHIZOAFFECTIVE PSYCHOSIS; SUICIDAL BEHAVIOR; SUICIDE;

ANTICONVULSANTS; ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; DRUG THERAPY, COMBINATION; HUMANS; LITHIUM COMPOUNDS; SUICIDE; SUICIDE, ATTEMPTED;

EID: 34548839605     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jad.2007.08.001     Document Type: Editorial

References (24)

1. Ahrens B., and Muller-Oerlinghausen B. Does lithium exert and independent antisuicidal effect?. Pharmacopsychiatry 34 (2001) 132-136
2. Akiskal H.S., and Mallya G. Criteria for the "soft" bipolar spectrum: treatment implications. Psychopharmacol. Bull. 23 (1987) 68-73
3. Akiskal H.S., and Benazzi F. Psychopathologic correlates of suicidal ideation in major depressive outpatients: is it all due to unrecognized bipolar depressive mixed states?. Psychopathology 38 (2005) 273-280
4. Angst J., Angst F., Gerber-Werder R., and Gamma A. Suicide in 406 mood disorder patients with and without longterm medication: a 40-44-year follow-up. Arch. Suic. Res. 9 (2005) 279-300
5. Balazs J., Benazzi F., Rihmer Z., Rihmer A., Akiskal K.K., and Akiskal H.S. The close link between suicide attempts and mixed (bipolar) depression: implications for suicide prevention. J. Affect. Disord. 91 (2006) 133-138
6. Baldessarini R.J., Tondo L., Davis P., Pompili M., Goodwin F.K., and Hennen J. Decreased risk of suicides and attempts during long-term lithium treatment: a meta-analytic review. Bipol. Disord. 8 (2006) 625-639
7. Cipriani A., Pretty H., Hawton K., and Geddes J.R. Lithium in the prevention of suicidal behavior and all-cause mortality in patients with mood disorders: a systematic review of randomized trials. Amer. J. Psychiatry 162 (2005) 1805-1819
8. Ghaemi S.N., Hsu D.J., Soldani F., and Goodwin F.K. Antidepressants in bipolar disorder: the case of caution. Bipol. Disord. 5 (2003) 421-433
9. Goodwin F.K., Fireman B., Simon G.E., Hunkeler E.M., Lee Y., and Revicki D. Suicide risk in bipolar disorder during treatment with lithium and divalproex. JAMA 290 (2003) 1467-1473
10. In: Hawton K., and van Heeringen K. (Eds). International Handbook of Suicide and Attempted Suicide (2000), John Wiley and Sons, Chichester
11. Koukopopulos A., Faedda G., Proietti R., D'Amico S., de Pisa E., and Simonetto C. Mixed depressive syndrome. Encephale 18 (1992) 19-21
12. Luoma J.B., Martin C.E., and Pearson J.L. Contact with mental health and primary care providers before suicide: a review of the evidence. Am. J. Psychiatry 159 (2002) 909-916
13. McElroy S.L., Kotwal R., Kaneria R., and Keck Jr. P.E. Antidepressants and suicidal behavior in bipolar disorder. Bipol. Disord. 8 (2006) 596-617
14. Pirkis J., and Burgess P. Suicide and recency of health care contacts. A systematic review. Brit. J. Psychiatry 173 (1998) 462-474
15. Rihmer Z. Prediction and prevention of suicide in bipolar disorders. Clin. Neuropsychiatry 2 (2005) 48-54
16. Rihmer Z. Suicide risk in mood disorders. Curr Opin. Psychiatry 20 (2007) 17-22
17. Rihmer Z., and Akiskal H.S. Do antidepressants t(h)reat(en) depressives? Toward a clinically judicious formulation of the antidepressant-suicidality FDA advisory in light of declining national suicide statistics from many countries. J. Affect. Disord. 94 (2006) 3-13
18. Sondergard, L., Lopez, A.G., Andersen, P.K., Kessing, L.V., (in press). Mood stabilizing pharmacological treatment in bipolar disorders and risk of suicide. Bipol. Disord, 9
19. Thies-Flechtner K., Muller-Oerlinghausen B., Seibert W., Walther A., and Greil W. Effect of prophylactic treatment on suicide risk in patients with major affective disorders. Data from a randomized prospective trial. Pharmacopsychiatry 29 (1996) 103-107
20. Tondo L., and Baldessarini R.J. Suicidal risk in bipolar disorder. Clin. Neuropsychiatry 2 (2005) 55-65
21. Yerevanian B.I., Koek R.J., and Mintz J. Lithium, anticonvulsants and suicidal behavior in bipolar disorder. J. Affect. Disord. 73 (2003) 223-228
22. Yerevanian, B.I., Koek, R.J., Mintz, J., 2007a-this issue. Bipolar pharmacotherapy and suicidal behavior: part 1: lithium, divalproex and carbamazepine. J. Affect. Disord. doi:10.1016/j.jad.2007.05.019.
23. Yerevanian, B.I., Koek, R.J., Mintz, J., Akiskal, H.S., 2007b-this issue. Bipolar pharmacotherapy and suicidal behavior: part 2: the impact of antidepressants. J. Affect. Disord. doi:10.1016/j.jad.2007.05.017.
24. Yerevanian, B.I., Koek, R.J., Mintz, J., 2007c-this issue. Bipolar pharmacotherapy and suicidal behavior: part 3: impact of antipsychotics. J. Affect. Disord. doi:10.1016/j.jad.2007.05.018.